School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.
Department of Head and Neck Surgery, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Eur Arch Otorhinolaryngol. 2024 May;281(5):2667-2678. doi: 10.1007/s00405-024-08564-6. Epub 2024 Mar 26.
Transoral robotic surgery is well established in the treatment paradigm of oropharyngeal pathology. The Versius Surgical System (CMR Surgical) is a robotic platform in clinical use in multiple specialities but is currently untested in the head and neck. This study utilises the IDEAL framework of surgical innovation to prospectively evaluate and report a first in human clinical experience and single centre case series of transoral robotic surgery (TORS) with Versius.
Following IDEAL framework stages 1 and 2a, the study evaluated Versius to perform first in human TORS before transitioning from benign to malignant cases. Iterative adjustments were made to system setup, instrumentation, and technique, recorded in accordance with IDEAL recommendations. Evaluation criteria included successful procedure completion, setup time, operative time, complications, and subjective impressions. Further evaluation of the system to perform four-arm surgery was conducted.
30 TORS procedures were successfully completed (15 benign, 15 malignant) without intraoperative complication or conversion to open surgery. Setup time significantly decreased over the study period. Instrumentation challenges were identified, urging the need for TORS-specific instruments. The study introduced four-arm surgery, showcasing Versius' unique capabilities, although limitations in distal access were observed.
TORS is feasible with the Versius Surgical System. The development of TORS-specific instruments would benefit performance and wider adoption of the system. 4-arm surgery is possible however further evaluation is required. Multicentre evaluation (IDEAL stage 2b) is recommended.
经口机器人手术在口咽病理学的治疗模式中已得到充分确立。Versius 手术系统(CMR 外科)是一种在多个专业领域中临床应用的机器人平台,但尚未在头颈部进行测试。本研究利用外科创新的 IDEAL 框架,前瞻性地评估和报告首例人类经口机器人手术(TORS)与 Versius 的临床经验和单中心病例系列。
在 IDEAL 框架的第 1 阶段和第 2a 阶段之后,该研究评估了 Versius 进行首例人类 TORS 的性能,然后再从良性病例过渡到恶性病例。根据 IDEAL 建议,对系统设置、仪器和技术进行了反复调整。评估标准包括手术的成功完成、设置时间、手术时间、并发症和主观印象。进一步评估了系统进行四臂手术的能力。
成功完成了 30 例 TORS 手术(15 例良性,15 例恶性),术中无并发症,也无需转为开放性手术。在研究期间,设置时间显著缩短。发现了仪器挑战,迫切需要开发 TORS 专用仪器。本研究引入了四臂手术,展示了 Versius 的独特功能,尽管在远端访问方面存在一些限制。
Versius 手术系统可进行 TORS。开发 TORS 专用仪器将有利于提高系统的性能和广泛应用。四臂手术是可行的,但需要进一步评估。建议进行多中心评估(IDEAL 阶段 2b)。